Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Blood|March 7, 2009
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet StudyMichele Baccarani, Gianantonio Rosti, Fausto Castagnetti, et al.
Leukemia & Lymphoma|October 27, 2006
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phaseUlla Olsson-Strömberg, Martin Höglund, Magnus Björkholm, et al.
The New England Journal of Medicine|March 15, 2003
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemiaStephen G O'Brien, François Guilhot, Richard A Larson, et al.
Acta Haematologica|May 5, 2005
Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-upBengt Simonsson, Gunnar Oberg, Mats Bjoreman, et al.
Blood|June 21, 2011
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemiaBengt Simonsson, Tobias Gedde-Dahl, Berit Markevärn, et al.
The New England Journal of Medicine|December 8, 2006
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemiaBrian J Druker, François Guilhot, Stephen G O'Brien, et al.
Blood|June 28, 2013
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013Michele Baccarani, Michael W Deininger, Gianantonio Rosti, et al.
Haematologica|November 5, 2010
The European LeukemiaNet: achievements and perspectivesRüdiger Hehlmann, David Grimwade, Bengt Simonsson, et al.
Pageof 4